Concord Medical Valuation
| CCM Stock | USD 3.83 0.08 2.05% |
At this time, the firm appears to be fairly valued. Concord Medical Services shows a prevailing Real Value of $3.77 per share. The current price of the firm is $3.83. Our model approximates the value of Concord Medical Services from analyzing the firm fundamentals such as Profit Margin of (0.80) %, return on equity of -0.32, and Current Valuation of 463.24 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Concord Medical's valuation include:
Price Book 3.0038 | Enterprise Value | Enterprise Value Ebitda (0.96) | Price Sales 0.0353 | Enterprise Value Revenue 7.1187 |
Fairly Valued
Today
Please note that Concord Medical's price fluctuation is very risky at this time. Calculation of the real value of Concord Medical Services is based on 3 months time horizon. Increasing Concord Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Concord stock is determined by what a typical buyer is willing to pay for full or partial control of Concord Medical Services. Since Concord Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Concord Stock. However, Concord Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.83 | Real 3.77 | Hype 3.83 | Naive 3.91 |
The intrinsic value of Concord Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Concord Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Concord Medical Services helps investors to forecast how Concord stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Concord Medical more accurately as focusing exclusively on Concord Medical's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Concord Medical's intrinsic value based on its ongoing forecasts of Concord Medical's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Concord Medical's closest peers.
Concord Medical Cash |
|
Concord Valuation Trend
Knowing Concord Medical's actual value is paramount for traders when making sound investment determinations. Using both Concord Medical's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Concord Medical Total Value Analysis
Concord Medical Services is currently forecasted to have company total value of 463.24 M with market capitalization of 16.63 M, debt of 3.3 B, and cash on hands of 157.39 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Concord Medical fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
463.24 M | 16.63 M | 3.3 B | 157.39 M |
Concord Medical Investor Information
About 18.0% of the company shares are held by company insiders. The company recorded a loss per share of 11.99. Concord Medical Services last dividend was issued on the 23rd of December 2015. The entity had 1:10 split on the 30th of July 2024. Concord Medical Services may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.Concord Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Concord Medical has an asset utilization ratio of 8.88 percent. This suggests that the Company is making $0.0888 for each dollar of assets. An increasing asset utilization means that Concord Medical Services is more efficient with each dollar of assets it utilizes for everyday operations.Concord Medical Ownership Allocation
The market capitalization of Concord Medical Services is $16.63 Million. Concord Medical Services shows 17.99 percent of its outstanding shares held by insiders and 0.11 percent owned by other corporate entities. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Concord Medical Profitability Analysis
The company reported the last year's revenue of 537.4 M. Reported Net Loss for the year was (297.66 M) with loss before taxes, overhead, and interest of (80.78 M).About Concord Medical Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Concord Medical Services. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Concord Medical Services based exclusively on its fundamental and basic technical indicators. By analyzing Concord Medical's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Concord Medical's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Concord Medical. We calculate exposure to Concord Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Concord Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -68.9 M | -65.5 M | |
| Pretax Profit Margin | (1.19) | (1.13) | |
| Operating Profit Margin | (0.99) | (0.94) | |
| Net Loss | (0.64) | (0.67) | |
| Gross Profit Margin | (0.14) | (0.16) |
Concord Medical Growth Indicators
Investing in growth stocks can be very risky. If the company such as Concord Medical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 131.1 M |
Concord Medical Current Valuation Indicators
Concord Medical's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Concord Medical's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Concord Medical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Concord Medical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Concord Medical's worth.When determining whether Concord Medical Services is a strong investment it is important to analyze Concord Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Concord Medical's future performance. For an informed investment choice regarding Concord Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.99) | Revenue Per Share | Quarterly Revenue Growth (0.23) | Return On Assets | Return On Equity |
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.